Stock Events

Stock Events

Search...

Calidi Biotherapeutics (CLDI) Q3 2024 Earnings

13AugConfirmed

Q2 2024

Q3 2024

-2.75

-2.3

-1.85

-1.4

Details

Expected EPS

-1.45

Actual EPS

-1.4

Surprise EPS

0.05

Surprise Percent

+3.45%

Description

Calidi Biotherapeutics (CLDI) has reported earnings of -1.4 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.